CA2870466A1 - Ocular therapeutics using embryonic stem cell microvesicles - Google Patents

Ocular therapeutics using embryonic stem cell microvesicles Download PDF

Info

Publication number
CA2870466A1
CA2870466A1 CA2870466A CA2870466A CA2870466A1 CA 2870466 A1 CA2870466 A1 CA 2870466A1 CA 2870466 A CA2870466 A CA 2870466A CA 2870466 A CA2870466 A CA 2870466A CA 2870466 A1 CA2870466 A1 CA 2870466A1
Authority
CA
Canada
Prior art keywords
cells
esmv
retinal
muller
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2870466A
Other languages
English (en)
French (fr)
Inventor
Steven D. Schwartz
Debora B. Farber
Diana Katsman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, San Diego filed Critical University of California, San Diego
Publication of CA2870466A1 publication Critical patent/CA2870466A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/45—Artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2870466A 2012-04-16 2013-03-13 Ocular therapeutics using embryonic stem cell microvesicles Abandoned CA2870466A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261624701P 2012-04-16 2012-04-16
US61/624,701 2012-04-16
PCT/US2013/030733 WO2013158258A1 (en) 2012-04-16 2013-03-13 Ocular therapeutics using embryonic system cell microvesicles

Publications (1)

Publication Number Publication Date
CA2870466A1 true CA2870466A1 (en) 2013-10-24

Family

ID=49383920

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2870466A Abandoned CA2870466A1 (en) 2012-04-16 2013-03-13 Ocular therapeutics using embryonic stem cell microvesicles

Country Status (8)

Country Link
US (1) US20150079047A1 (cg-RX-API-DMAC7.html)
EP (1) EP2838995A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015514760A (cg-RX-API-DMAC7.html)
KR (1) KR20150009541A (cg-RX-API-DMAC7.html)
AU (1) AU2013249786A1 (cg-RX-API-DMAC7.html)
CA (1) CA2870466A1 (cg-RX-API-DMAC7.html)
IL (1) IL235126A0 (cg-RX-API-DMAC7.html)
WO (1) WO2013158258A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101334404B1 (ko) * 2011-04-28 2013-12-12 포항공과대학교 산학협력단 배아줄기세포 유래의 인공 마이크로베시클을 이용한 역분화 유도만능줄기세포의 제조방법
US11653636B2 (en) * 2019-11-15 2023-05-23 University Of Ulsan Foundation For Industry Cooperation Method of making a rat model of retinal degeneration and rat model made thereby
JP7007770B1 (ja) * 2021-06-21 2022-02-10 パナジー株式会社 眼症状改善剤および眼症状の改善方法
KR20230129828A (ko) 2022-03-02 2023-09-11 포항공과대학교 산학협력단 안구 후방 질환 또는 손상의 예방 또는 치료용 조성물
CN117379533B (zh) * 2022-07-11 2026-06-26 暨南大学 NeuroD1在制备将视网膜穆勒胶质细胞转化为神经元的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824685A (en) * 1995-02-01 1998-10-20 The Johns Hopkins University School Of Medicine Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
CN1307300C (zh) * 2002-07-25 2007-03-28 斯克里普斯研究学院 造血干细胞和治疗新生血管性眼部疾病的方法
AU2003280824A1 (en) * 2002-11-15 2004-06-15 Fumihiko Ishikawa Method of organ regeneration
RU2403906C2 (ru) * 2005-02-24 2010-11-20 Дзе Скриппс Рисерч Инститьют Способ лечения ретинопатии при недоношенности и родственных ретинопатических заболеваний
BRPI0615974A2 (pt) * 2005-07-27 2011-05-31 University Of Florida Research Foundation, Inc., uso de choque térmico para tratar uma doença ocular em um indivìduo, método para recrutar uma célula-tronco para um tecido ocular de um indivìduo com necessidade da mesma, uso de choque térmico para tratar uma doença ou um distúrbio ocular em um indivìduo com necessidade do mesmo, uso de choque térmico para regenerar a retina em um indivìduo com necessidade do mesmo, uso de choque térmico para reparar os danos ao epitélio pgmentar da retina em um indivìduo com necessidade do mesmo, uso de choque térmico para tratar a degeneração macular em um indivìduo com necessidade do mesmo, composição farmacêutica para o recrutamento de células-tronco, composição farmacêutica para recrutamento de células-tronco em um tecido ocular, kit e método para identificar um agente que aumenta o recrutamento de células-tronco em um tecido ocular
GEP20135796B (en) * 2006-03-07 2013-04-10 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
CN101854941B (zh) * 2007-10-29 2013-03-27 弗雷森纽斯医疗护理德国有限责任公司 衍生自干细胞的微泡(MVs)用于制备用于受损或损伤组织或器官的内皮/上皮再生的药物的用途、以及相关体外和体内方法
NZ586497A (en) * 2008-01-04 2012-07-27 Lydac Neuroscience Ltd Microvesicles
EP2486126B1 (en) * 2009-10-06 2017-12-06 SNU R & DB Foundation Method for differentiation into retinal cells from stem cells
EP2603592A2 (en) * 2010-08-13 2013-06-19 The University Court of the University of Glasgow Therapeutic uses of microvesicles and related micrornas
JP5872041B2 (ja) * 2011-08-16 2016-03-01 サムスン ライフ パブリック ウェルフェア ファンデーション 幹細胞由来微小胞を含む神経生成促進用組成物
US20160022743A1 (en) * 2012-05-31 2016-01-28 The Schepens Eye Research Institute, Inc. Human very small embryonic-like (vsel) stem cells for treatment of ocular disease

Also Published As

Publication number Publication date
EP2838995A1 (en) 2015-02-25
JP2015514760A (ja) 2015-05-21
EP2838995A4 (en) 2016-01-06
WO2013158258A8 (en) 2014-09-04
US20150079047A1 (en) 2015-03-19
WO2013158258A1 (en) 2013-10-24
KR20150009541A (ko) 2015-01-26
IL235126A0 (en) 2014-12-31
AU2013249786A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
Katsman et al. Embryonic stem cell-derived microvesicles induce gene expression changes in Müller cells of the retina
Dubbelaar et al. The kaleidoscope of microglial phenotypes
Sun et al. Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation
Roybon et al. Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes
CN104321062B (zh) 干细胞微粒
US20150079047A1 (en) Ocular therapeutics using embryonic stem cell microvesicles
TR201903889T4 (tr) Korneal endotelyal hücreler üreten yönlendirilmiş diferansiyasyona yönelik yöntem.
CN105142646A (zh) 产生微粒的方法
CN104718283A (zh) 从头生成多能细胞
JP2015510401A (ja) ヒト疾患のインビトロモデル化および細胞に基づく治療のための間葉系幹細胞ならびにそのバンク
Lozano-Ureña et al. IGF2 interacts with the imprinted gene Cdkn1c to promote terminal differentiation of neural stem cells
Lattanzi et al. Neurotrophic features of human adipose tissue‐derived stromal cells: in vitro and in vivo studies
US11492596B2 (en) Methods for differentiating cells into hepatic stellate cells
Kang et al. RETRACTED ARTICLE: Stem-like cells of various origins showed therapeutic effect to improve the recovery of spinal cord injury
Hsi et al. Extracellular vesicles as biomarkers for traumatic brain injury using a 3D in vitro human brain tissue model
JP2025111573A (ja) 高増殖性細胞の製造方法、高増殖性細胞およびその用途
US20240254440A1 (en) Methods to generate glial restricted neural progenitor cells and uses thereof
CN119584975A (zh) 治疗脑损伤的方法
KR20180117070A (ko) 신규 줄기세포 치료제
Ali et al. Directed differentiation of umbilical cord blood stem cells into cortical GABAergic neurons
Xu et al. Reversing abnormal neural development by inhibiting OLIG2 in down syndrome human iPSC brain organoids and neuronal mouse chimeras
Lovejoy iPSC derived cerebral organoids as a model of tauopathy
Rümmele Exploring the regulation of human neural stem cells quiescence using a CRISPR/Cas9 approach
Sun Exploring the Cellular and Molecular Features of Human Astrocytes with Rett Syndrome-Causing MEPC2 Mutations
Hou et al. and Hung-Chih Kuo

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190313